Table 1:

Criteria for diabetes remission.

Remission should be defined as a return of HbA1c to < 6.5% (< 48 mmol/mol) that occurs spontaneously or following an intervention and that persists for at least 3 months in the absence of usual glucose-lowering pharmacotherapy
When HbA1c is determined to be an unreliable marker of chronic glycemic control, FPG < 126 mg/dL (< 7.0 mmol/L) or eA1C < 6.5% calculated from CGM values can be used as alternate criteria
Testing of HbA1c to document a remission should be performed just prior to an intervention and no sooner than 3 months after initiation of the intervention and withdrawal of any glucose-lowering pharmacotherapy
Subsequent testing to determine long-term maintenance of a remission should be done at least yearly thereafter, together with the testing routinely recommended for potential complications of diabetes
Remission should be defined as a return of HbA1c to < 6.5% (< 48 mmol/mol) that occurs spontaneously or following an intervention and that persists for at least 3 months in the absence of usual glucose-lowering pharmacotherapy
When HbA1c is determined to be an unreliable marker of chronic glycemic control, FPG < 126 mg/dL (< 7.0 mmol/L) or eA1C < 6.5% calculated from CGM values can be used as alternate criteria
Testing of HbA1c to document a remission should be performed just prior to an intervention and no sooner than 3 months after initiation of the intervention and withdrawal of any glucose-lowering pharmacotherapy
Subsequent testing to determine long-term maintenance of a remission should be done at least yearly thereafter, together with the testing routinely recommended for potential complications of diabetes